WATCHMAN™ Left Atrial Appendage Closure (LAAC) Device

Boston Scientific’s GuidePoint Reimbursement Resources are designed to assist physician and hospital providers in navigating the coding, coverage, and payment environment for innovative technologies such as the WATCHMAN LAAC Device.

On February 8, 2016, the Centers for Medicare and Medicaid Services (CMS) established coverage for WATCHMAN under a National Coverage Determination (NCD 20.34) for percutaneous Left Atrial Appendage Closure therapy (LAAC). The NCD provides appropriate and uniform coverage for Medicare beneficiaries when specific conditions are met. Coverage requirements are detailed within our reimbursement resources available here. Many private payers have also established positive coverage policies for WATCHMAN LAA, current plans with published policies are listed here. Boston Scientific also provides physicians and hospitals with assistance in seeking coverage for WATCHMAN LAAC procedures on a case-by-case basis from private payers without established policies.

To access the NCD in it’s entirety, please visit the final decision memo.

To view and download a comprehensive list of WATCHMAN Reimbursement materials, please visit WATCHMAN Download Center.

Importance of Documentation

This guide stresses the importance of documentation in capturing the appropriate acuity level for patients considered WATCHMAN candidates. It helps provide an overview of the common complications and comorbidities that assist with the MS-DRG assignment based on patient medical appropriateness.

Hospital Charging Guide

This guide provides education to hospitals on the importance of appropriate charging practices for high cost implantable devices such as the WATCHMAN LAAC Device. 

Provider Intake Form

Template to assist providers with appealing denials by utilizing the criteria of the NCD for percutaneous LAAC therapy in referencing patient’s eligibility. 

Sample Appeals Template

Template to assist providers with appealing denials by utilizing the criteria of the NCD for percutaneous LAAC therapy in referencing patient’s eligibility.

Reimbursement Guide

This comprehensive guide provides an overview of the coding, coverage and payment landscape for the WATCHMAN system.

Questions?

For questions regarding WATCHMAN reimbursement, please contact:

  watchman.reimbursement@bsci.com

  877-786-1050

Messages are monitored M-F, 8am-4pm CT and responses are typically on the same or following business day.

FDA Approval Letter

FDA Approval Letter

View Now

Join GuidePoint!

Join Now

GuidePoint Webinars

Learn More